Cell Therapy Seen to Ease Blood Loss in Hemophilia A Mouse Model
Endothelial cells — those that line the inside of blood vessels — derived from stem cells of people with…
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Endothelial cells — those that line the inside of blood vessels — derived from stem cells of people with…
Express Scripts has teamed up with PinnacleCare to include in its new Rare Conditions Care Value (RCCV) program a service…
US Bioservices, a specialty pharmacy, announced that it is working with the pharmacy benefit management company MedImpact to dispense…
A gene therapy approach acquired by uniQure was recently covered in two new patents, one issued in the United…
Hemlibra (emicizumab-kxwh) was recently granted priority review status by the U.S. Food and Drug Administration following the agency’s acceptance…
Patient advocacy groups in five states will focus on the challenges affecting patients with blood disorders like hemophilia with the…
The Arizona Hemophilia Association (AHA) is inviting camp professionals in the bleeding disorders and hemophilia communities to participate…
The National Heart, Lung and Blood Institute (NHLBI) is hosting a State of the Science Workshop on May…
In recognition of World Hemophilia Day 2018, the biopharmaceutical company Bioverativ is sharing the stories of people with hemophilia in the…
Magellan Rx Management, the pharmacy benefit management division of Magellan Health, recently shared results from the first six months…
Get regular updates to your inbox.